Drug Companies Face COVID Cliff In 2023 As Sales Set To Plummet
Pharmaceutical companies that made billions from the pandemic over the past two years selling vaccines and treatments are now up against a steep COVID cliff and investor pressure to spend their
Source: ibtimes.com